1. Introduction {#sec1}
===============

To improve the overall quality of life, natural products have been utilized for many different purposes, including as industrial supplements, flavors or fragrances. Among natural products, carotenoids are one of the most common. Carotenoids represent a subfamily of terpenoids that usually contain 40 carbon atoms with 8 isoprene molecules and have yellow, orange, and red hues attributable to an extensively conjugated polyene chain. This characteristic chemical structure is responsible for their physiological function as an antioxidant and provitamin A nutrient, as well as its ability to protect from UV radiation. In fungi, for example, carotenoids play a key role as potent photoprotective and stress-protecting agents ([@bib11]). Moreover, carotenoids are reported to play a vital role in gene regulation and apoptosis in mammalian cells ([@bib125]; [@bib132]), which are metabolic processes essential for maintaining the health of animals.

Owing to these biological activities, carotenoids have been widely used as additives in food and feed, nutraceuticals, and cosmetics ([@bib114]). The global market for carotenoids is reported to reached \$1.5 billion in 2018, and will increase to an estimated value of \$2.0 billion in 2022 ([@bib93]). Although the demand for carotenoids is rapidly increasing, their supply is limited due to inefficient production methods ([@bib7]; [@bib113]). Many of the structurally more complex carotenoids cannot be chemically synthesized via economically viable methods ([@bib165]). Most carotenoids are extracted from natural sources with low yields due to complicated multi-step processes and low concentrations in the raw materials, which can also be further affected by unfavorable environmental conditions ([@bib1]; [@bib86]). Therefore, microbial production of carotenoids provides an attractive alternative, as it does not require direct land use or the time invested to grow crops for harvest and extraction. Recent advances in genetic and metabolic engineering of microorganisms make it increasingly possible to modify, design and optimize host microorganisms to be advanced microbial cell factories ([@bib56]; [@bib91]; [@bib120]). Combining different strategies and advanced metabolic engineering tools will enable the microbial production of carotenoids to achieve high yields and meet the increasing carotenoid demand. Recently, a systematic approach was developed to engineer secondary metabolism described as 'multivariate modular metabolic engineering' (MMME) ([@bib2]). Reduced regulatory complexities are achieved by grouping multiple genes into modules as a method to assess and eliminate regulatory and pathway bottlenecks ([@bib155]; [@bib163]). Using a MMME approach, the microbial biosynthesis of carotenoids can be divided into four distinct modules ([Fig. 1](#fig1){ref-type="fig"}). Increasing flux into these modules and balancing the metabolic flux among these modules become critical in order to obtain higher carotenoid yields. The main scope of this review is to describe key strategies and current advances in engineering these modules for maximizing carotenoid production.Fig. 1**Scheme of carotenoid biosynthesis.** The whole metabolic pathway divides into four modules, striating from a carbon source and leading to carotenoids. Enzymes are as follows. Isoprene supplement module: (1) MVA pathway: ACCT, Acetoacetyl-CoA thiolase; HMGS, HMG-CoA synthase; HMGR, HMG-CoA reductase; MK, mevalonate kinase; PMK, phosphomevalonate kinase; MDD, mevalonate diphosphate decarboxylase; Idi: isopentenyl pyrophosphate isomerase. (2) MEP pathway: Dxs, 1-deoxy-*D*-xylulose 5-phosphate synthase; Dxr, 1-deoxy-*D*-xylulose 5-phosphate reductoisomerase; IspD, 2-*C*-methyl-*D*-erythritol 4-phosphate cytidylyltransferase; IspE, 4-diphosphocytidyl-2-*C*-methyl-*D*-erythritol kinase; IspF, 4-diphosphocytidyl-2-Cmethyl-*D*-erythritol kinase; IspG, 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase; IspH, 4-hydroxy-3-methylbut-2-enyl diphosphate reductase. (3) IUP: CK, choline kinase; IPK, isopentenyl monophosphate kinase. Carotenoid biosynthesis module: CrtE, geranylgeranyl pyrophosphate synthase; CrtB, 15-cis-phytoene synthase; GFPPS, geranylfarnesyl diphosphate synthase. Abbreviations can be found in the appendix. The dashed arrows indicate multiple steps.Fig. 1

2. Biosynthesis of carotenoids {#sec2}
==============================

To date, more than one thousand natural carotenoids have been found in plants, microalgae, fungi and bacteria ([@bib154]). Carotenoids are derived from the universal isoprene (C5) precursors isopentenyl diphosphate (IPP) and its allylic isomer dimethylallyl diphosphate (DMAPP). These can be synthesized through two different natural pathways, the mevalonate (MVA) pathway and the 2-C-methyl-*D*-erythritol-4-phosphate (MEP) pathway, as well as an artificial pathway, the isopentenol utilization pathway (IUP) ([Fig. 1](#fig1){ref-type="fig"}) ([@bib19]). The MVA pathway is mainly present in eukaryotes and archaea, while the MEP pathway is typically found in most bacteria and plant plastids ([@bib13]). The substrates of the MVA and MEP pathways are acetyl-CoA, glyceraldehyde-3-phosphate (G3P) and pyruvate, all provided by the central carbon pathway ([@bib138]; [@bib167]). In addition, microbial hosts typically use the central carbon pathway to supply critical cofactors (ATP and NADPH) for carotenoid biosynthesis ([@bib4]). To produce one molecule of IPP, 1.5 molecules of glucose and three molecules of ATP are consumed and four molecules of NADPH are produced using the MVA pathway, while one molecule of glucose, three molecules of ATP and two molecules of NADPH are required using the MEP pathway ([@bib79]).

In the MVA pathway, two molecules of acetyl-CoA are condensed to form 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA), followed by a reduction step that generates mevalonate and three phosphorylation steps and one decarboxylation step to produce IPP ([Fig. 1](#fig1){ref-type="fig"}) ([@bib96]). The biosynthesis of IPP in the MEP pathway begins with the condensation of G3P and pyruvate, followed by a reductive isomerization reaction, a subsequent coupling with cytidine triphosphate (CTP), and finally a phosphorylation and cyclization reaction ([Fig. 1](#fig1){ref-type="fig"}) ([@bib96]).

In the IUP, the substrate is the isopentenol isomer isoprenol or/and prenol, which can be directly supplemented in production media ([@bib19]; [@bib85]) or introduced via intracellular biosynthesis ([@bib27]). One molecule of isoprenol/prenol and two molecules of ATP are consumed to produce one molecule of IPP/DMAPP ([@bib19]). The IUP only contains two steps through sequential phosphorylation of isoprenol/prenol, compared with six steps in the MVA pathway and seven steps in the MEP pathway ([Fig. 1](#fig1){ref-type="fig"}).

Following the generation of the isoprene precursors, one molecule of DMAPP and three molecules of IPP are condensed into one geranylgeranyl diphosphate (GGPP) in three prenyl-transferase reactions ([Fig. 1](#fig1){ref-type="fig"}). Two molecules of GGPP can be condensed to form phytoene (C40). Four double bonds are introduced into phytoene to form lycopene, which then becomes a precursor to a variety of carotenoids, e.g., lycopene, β-carotene, zeaxanthin and astaxanthin ([Fig. 2](#fig2){ref-type="fig"}). During the condensation of DMAPP and IPPs, variation of the prenyltransferases of the condensation reactions can form farnesyl diphosphate (FPP, C15) and geranylfarnesyl diphosphate (GFPP, C25), which serve as the precursors of minor C30 and C50 carotenoids ([@bib134]). The C50 carotenoids can be elongated with isoprene units by lycopene C5-elongases and C50-cyclases to generate unique C60 carotenoids ([@bib78]).Fig. 2**Derivatives of lycopene.** Enzymes are as follows: LcbB, lycopene bifunctional β-cyclase; Bhy, β-carotene hydroxylase; CrtW, β-carotene 4-ketolase; CCD1, carotenoid cleavage dioxygenase 1; Blh, 15, 15 cleavage dioxygenase; Rdh, retinol dehydrogenase; LcmE, lycopene monofunctional ε-cyclase; Cehy, α-hydroxylase; LcbE, lycopene bifunctional ε-cyclase. The dashed arrows indicate multiple steps.Fig. 2

3. Modular engineering for carotenoids production {#sec3}
=================================================

Potential commercial interests in sustainable industrial production of carotenoids have led to research breakthroughs that increase carotenoid titer via metabolic engineering. A summary of these strategies can be found in [Table 1](#tbl1){ref-type="table"}. The basic principle of metabolic engineering is to maximize carbon flux from substrates to the target compound while minimizing flux to unnecessary byproducts. The carotenoid biosynthesis pathways, in particular, can be divided into four metabolism modules: 1) central carbon metabolism, 2) cofactor metabolism, 3) isoprene supplement metabolism, and 4) carotenoid biosynthesis ([Fig. 1](#fig1){ref-type="fig"}). Increasing and balancing carbon flux into and among these modules is important for carotenoid overproduction.Table 1Carotenoid production in microorganisms using various metabolic engineering strategies.Table 1Major carotenoidHost microorganismFermentation conditionsYield (titer or/and content)Metabolic engineering approachReferenceLycopene*Escherichia coli*Shake Flask448 ​mg/gRegulation of lycopene synthesis pathway[@bib29]Lycopene*Escherichia coli*Batch220 ​mg/LIntroduction of IUP[@bib19]Lycopene*Saccharomyces cerevisiae*Fed-batch2300 ​mg/LModular enzyme assembly[@bib64]β-carotene*Escherichia coli*Shake Flask44.2 ​mg/gIncreasing membrane synthesis[@bib146]β-carotene*Escherichia coli*Fed-batch2100 ​mg/LEngineering central metabolic modules[@bib167]β-carotene*Saccharomyces cerevisiae*Fed-batch2370 ​mg/L (73.3 ​mg/g)Combined modular engineering[@bib90]β-carotene*Yarrowia lipolytica*Fed-batch4000 ​mg/LIterative integration of multiple-copy pathway genes[@bib42]β-caroteneYarrowia lipolyticaFed-batch6500 ​mg/L (90 ​mg/g)Optimization of promoter-gene pairs of crt[@bib73]Astaxanthin*Corynebacterium glutamicum*Shake Flask1.7 ​mg/gScreening different β-carotene hydroxylases[@bib50]Astaxanthin*Escherichia coli*Fed-batch385.0 ​mg/L (7.0 ​mg/g)Membrane fused expression of β-carotene hydroxylase[@bib99]Astaxanthin*Escherichia coli*Fed-batch320 ​mg/LModular engineering[@bib163]

3.1. Engineering the carotenoid biosynthesis module {#sec3.1}
---------------------------------------------------

The carotenoids biosynthesis module is directly related to carotenoid yield ([@bib31]; [@bib134]). Inefficient carotenoid biosynthesis leads to a cellular accumulation of IPP/DMAPP that can be toxic to cells ([@bib122]) and a lower yield of carotenoids. To date, many strategies have been employed to engineer the carotenoid biosynthesis module, including selection of novel enzymes, engineering key enzymes, localized expression of key enzymes, optimization of gene expression and increasing carotenoid storage in producing cells ([Fig. 3](#fig3){ref-type="fig"}).Fig. 3**Strategies for engineering the carotenoid biosynthesis module.** Astaxanthin biosynthesis route is used as an example. Engineering enzymes to have higher activity, regulating their expression level, increasing carotenoid storage and localizing expression of enzymes to membranes can all increase carotenoid production. Enzymes are as follows: CrtE, geranylgeranyl pyrophosphate synthase; CrtB: 15-cis-phytoene synthase; CrtI: phytoene desaturase; LcbB: lycopene bifunctional β-cyclase; Bhy: β-carotene hydroxylase; CrtW: β-carotene 4-ketolase. Abbreviations can be found in the appendix. The dashed arrows indicate multiple steps.Fig. 3

### 3.1.1. Screening and engineering enzymes with high activity {#sec3.1.1}

Common cell factory hosts, e.g., *Escherichia coli* and *Saccharomyces cerevisiae*, do not harbor all the genes for carotenoid biosynthesis. Therefore, heterologous genes are required to construct a carotenoid biosynthesis pathway. Heterologous proteins have different expression levels in different hosts ([@bib33]) so gene sources for carotenoid biosynthesis need to be well chosen. In *E. coli*, for example, changing the *crtE*/*B*/*I* genes from *Pantoea ananatis* to *Pantoea agglomerans* nearly doubles lycopene production ([@bib161]). In *S. cerevisiae*, the *crtE/B/I* genes from diverse species were screened and *crtE* from *Taxus x media*, *crtB* from *P. agglomerans*, and *crtI* from *Blakeslea trispora* resulted in the highest amounts of lycopene ([@bib25]). Besides plants, marine bacteria are another natural source for both common and uncommon valuable carotenoids ([@bib126]). β-carotene hydroxylase from the marine bacterium *Fulvimarina pelagi* allows a better astaxanthin production than that from *P. ananatis* in *Corynebacterium glutamicum* ([@bib50]). In addition, some novel bifunctional enzymes have been screened for carotenoid biosynthesis. Single genes encoding for a protein with both phytoene synthase and lycopene cyclase activities from several species ([@bib45]; [@bib84]; [@bib131]; [@bib139]) have been functionally analyzed and applied to carotenoid biosynthesis. These fusion enzymes can remove competition with precursors ([@bib16]) and aid in the elimination of unwanted side reactions ([@bib3]), leading towards high yields of target products. Artificial fused proteins have similar benefits. An engineered carotenoid cleavage dioxygenase 1 (CCD1) from *Osmanthus fragans* (OfCCD1) was fused with lycopene ε-cyclase, facilitating substrate channeling and increasing product production by fifty percent ([@bib22]).

Identified and screened wild-type enzymes usually have low activity, low affinity, and insufficient expression levels in heterologous hosts. Multiple approaches employing protein engineering and expression level regulation have been developed to improve carotenoid production. Due to the inherent color of carotenoids, simple, color-based high-throughput screening methods have been developed for isolating positive mutants. The following directed evolution studies all utilized color-based screening methods to improve enzyme function and activity. At the beginning of carotenoid biosynthesis, DMAPP to GGPP conversion by GGPP synthase was found to be a rate-limiting step ([@bib63]). In order to increase flux through this pathway, directed evolution of GGPP synthase ([@bib55]; [@bib75]; [@bib133]) has been applied to increase carotenoid production. Similarly, directed evolution of a bifunctional enzyme containing phytoene synthase and lycopene cyclase ([@bib148]), as well as the single enzyme β-carotene ketolase ([@bib176], [@bib175]), also increased carotenoid production. In addition, a mutant FPP synthase that altered its chain-length specificity ([@bib74]) can also increase GGPP synthesis and supply needs for downstream products. Besides random mutations, rational design has been developed to generate mutants of CCD1 from *Petunia hybrid* (PhCCD1) ([@bib141]) and the aforementioned OfCCD1 ([@bib22]), which increased production of derivatives from β-carotene and ε-carotene by 300% and 200%, respectively.

In addition to single/multiple point mutations of key enzymes, several researchers have explored engineering the N/C-terminal for enhancing carotenoid biosynthesis. Since enzyme activity and solubility are correlated for a variety of proteins ([@bib172]), N/C-terminal fusion tags that significantly affect protein solubility were tested for improved overall activity ([@bib38]). As an example, the solubility of enzymes involved in the synthesis of the terpene taxadiene was optimized through a Cas9-based toolkit ([@bib112]), including 10 fusion tags, which increased taxadiene production by 15-fold. This toolkit could be further explored for improving carotenoid production. In another example, a truncation of 50-residues in the N-terminal of lycopene ε-cyclase from *Lactuca sativa*, which is thought to enhance its solubility and activity, increased ε-lycopene production by 122% ([@bib162]). In addition to protein engineering for high solubility, a machine learning-based regression predictive model has been developed to predict lycopene β-cyclase solubility based on the known solubility of proteins in the solubility dataset ([@bib46]). Using this method, enzymes with higher solubility can be selected from the protein database (PDB) and analyzed, which can then be applied in carotenoid overproduction. Fusion tags can also affect protein stabilization and improve production ([@bib66]). A fusion tag from thioredoxin (trxA) was attached to both the N- and C- terminals of a β-carotene ketolase from *Chlamydomonas reinhardtii* to allow stable expression, which increased astaxanthin production by 60% ([@bib99]).

After carotenoids are synthesized, they are expected to bind to lipid membranes due to their hydrophobicity ([@bib44]). Localizing enzymes to the membrane can offer a greater chance for enzymes to interact with the hydrophobic substrate, improving the overall conversion efficiency. Co-localizing β-carotene ketolase to the *E. coli* membrane using the signal peptide of outer membrane protein (OmpF) resulted in nearly 60% higher astaxanthin production ([@bib99]). Similarly, localizing PhCCD1 to the membrane through the signal peptide of rat lymphocyte cell-specific protein tyrosine kinase (Lck) increased ionone production by 170% ([@bib141]). In another example, β-carotene ketolase and hydroxylase fused to glycerol channel protein (GlpF) were localized to the membrane, increasing astaxanthin production by 215% ([@bib159]).

### 3.1.2. Regulating gene expression level {#sec3.1.2}

Other than protein engineering and localized expression, increasing efficiency in a given pathway is related to enzyme expression levels, which is considered to increase the metabolic flux towards target production. Overexpression of heterologous or endogenous proteins is related to a variety of aspects, including promoter engineering, ribosome binding site (RBS) engineering, gene copy number and gene regulation ([@bib54]; [@bib76]; [@bib102]). Selecting and mutating promoters from various heterologous sources has been applied to improve gene expression in carotenoid biosynthesis modules in both bacteria ([@bib108]) and yeast ([@bib42]; [@bib47]; [@bib73]) for carotenoid overproduction. In addition, engineering the RBS of key enzymes in carotenoid synthesis can also increase carotenoid production in *E. coli* ([@bib58]; [@bib136]; [@bib160]).

Another strategy to improve carotenoid production is to increase gene copy numbers of key enzymes ([@bib42]; [@bib50]; [@bib73]; [@bib118]) since gene copy number can be directly related to its protein expression level ([@bib54]). Due to the genetic instability of plasmids, an approach named "chemically induced chromosomal evolution" was applied to control gene copy integration into the chromosome by triclosan induction ([@bib23]; [@bib128]) for carotenoid overproduction. This method uses RecA to mediate DNA crossover between the leading and trailing homologous regions for high copy genome integration. In addition, the order of genes in the operon affected the yield of carotenoids since genes farther away from a promoter in an operon have lower levels of expression ([@bib28]; [@bib153]). Splitting up this large operon into smaller operons consisting of two or three genes controlled by a strong promoter can eliminate this issue and improve overall flux ([@bib158]).

The promoter controlling the carotenoid biosynthesis module can be repressed by various transcription factors and repressors, decreasing overall carotenoids production. Knocking out the crtR repressor, for example, deregulates the *crt* operon, leading to a several-fold increase of lycopene and β-carotene in *C. glutamicum* ([@bib49]). Increasing cofactor expression can also improve enzyme activity. Oxygen is a cofactor of β-carotene ketolase and hydroxylase, whose activities can be increased by introducing the hemoglobin gene from *Methylomonas* sp. 16a, improving astaxanthin conversion by 60% in *E. coli* ([@bib124]).

### 3.1.3. Engineering carotenoid storage {#sec3.1.3}

Carotenoid yield can be limited by the intracellular capacity of the host organism to store these molecules ([@bib44]) and the fact that high intracellular concentrations of carotenoids can be toxic to the host ([@bib122]). Increasing the ability of a host organism to store carotenoids while limiting toxic effects is therefore a major challenge. The yeast *Yarrowia lipolytica*, which can produce lipid bodies and store larger amounts of carotenoids ([@bib95]), is an excellent host for carotenoid overproduction because of its increased storage capacity and increasing the size of its lipid bodies can further enhance lycopene production ([@bib92]). Triacylglycerol lipid droplets were also introduced into a lycopene production strain of *S. cerevisiae* and increased lycopene production by 25% ([@bib90]).

Natural carotenoids are considered to be mainly stored in the membranes of plants and bacteria ([@bib44]). Increasing the amount of membrane structures and expanding the membrane surface area can increase carotenoid production in *E. coli* ([@bib146], [@bib145]). Overexpression of a glycerol-3-phosphate O-acyltransferase and a 1-acyl-sn-glycerol-3-phosphate acyltransferase that can increase membrane synthesis improved β-carotene production by 43%, while a monoglucosyldiacylglycerol synthase that can increase the total membrane area improved lycopene production by 37.5% ([@bib146]). Though increasing membrane synthesis can increase the intracellular storage of carotenoids in bacteria ([@bib44]), accumulation of carotenoids can disturb the membrane structure, which could have a toxic effect on cells. To address this problem, a novel artificial membrane vesicle transport system was constructed in *E. coli* to efficiently secrete hydrophobic molecules, leading to a 61% increase of β-carotene ([@bib144]). In this system, knockouts of *tolA* and *nlpI*, which encodes lipoproteins, was thought to enhance the outer membrane vehicles formation and thus increased OMV-mediated β-carotene excretion. This strategy could be applied to other hosts to improve total membrane storage of carotenoids. To relieve carotenoid toxicity, membrane flexibility was increased by overexpressing the gene encoding stearoyl-CoA 9-desaturase, leading to an increase of 30% lycopene production in *S. cerevisiae* ([@bib53]). In addition, various membrane components were modified (e.g. ergosterol) by overexpressing the gene *ino2*, which encodes for a transcription factor involved in stress response and biosynthesis of phospholipids and sterol, enhancing lycopene production in *S. cerevisiae* by nearly 10% ([@bib25]).

3.2. Engineering the isoprene supplement module {#sec3.2}
-----------------------------------------------

To obtain a high yield of microbial carotenoids, IPP is considered to be a key precursor ([@bib100]; [@bib129]). As introduced earlier, natural IPP is synthesized from the MVA and MEP pathways. Overexpression of the whole MEP or/and MVA pathway does not appear to increase the IPP precursor supply due to the accumulation of toxic intermediates and feedback inhibition ([@bib79]). Several methods, including optimized expression of key enzymes and regulation of the pathway has been applied to improve engineering the MVA and MEP pathways ([Fig. 4](#fig4){ref-type="fig"}).Fig. 4**Strategies for engineering central carbon, cofactor and isoprene supplement modules.** Enzymes are as follows. (1) Central carbon module: GapA, glyceraldehyde 3-phosphate dehydrogenase; Pps, phosphoenolpyruvate synthase; Por, pyruvate ferredoxin oxidoreductase; Ald6p, aldehyde dehydrogenase; Adh2, alcohol dehydrogenase; GltA, citrate synthase; AcnAB, aconitate hydratase; Icd, aconitate hydratase; SucAB, α-ketoglutarate dehydrogenase; SucCD, succinyl-CoA synthetase; SdhABCD, succinate dehydrogenase; FumAC, fumarate hydratase; Mdh, malate dehydrogenase. (2) Cofactor module: Zwf1, glucose 6-phosphate dehydrogenase; Pgl, 6-phosphogluconolactonase; Gnd, 6-phosphogluconate dehydrogenase; Rpe, ribulose 5-phosphate 3-epimerase; Rpi, ribose-5-phosphate isomerase; TktA, transketolase subunit A; TktB, transketolase subunit B; TalB, transaldolase; Nuo, NADH-quinone oxidoreductase; CYD, cytochrome bd-I oxidase; Cyo, cytochrome bo oxidase; Atp, ATP synthase. (3) Isoprene supplement module: MVA pathway: ACCT, Acetoacetyl-CoA thiolase; HMGS, HMG-CoA synthase; HMGR, HMG-CoA reductase; MK, mevalonate kinase; PMK, phosphomevalonate kinase; MDD, mevalonate diphosphate decarboxylase; Idi: isopentenyl pyrophosphate isomerase. MEP pathway: Dxs, 1-deoxy-*D*-xylulose 5-phosphate synthase; Dxr, 1-deoxy-*D*-xylulose 5-phosphate reductoisomerase; IspD, 2-*C*-methyl-*D*-erythritol 4-phosphate cytidylyltransferase; IspE, 4-diphosphocytidyl-2-*C*-methyl-*D*-erythritol kinase; IspF, 4-diphosphocytidyl-2-Cmethyl-*D*-erythritol kinase; IspG, 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase; IspH, 4-hydroxy-3-methylbut-2-enyl diphosphate reductase. IUP: CK, choline kinase; IPK, isopentenyl monophosphate kinase. RibB, 3,4-dihydroxy 2-butanone 4-phosphate synthase. Abbreviations can be found in the appendix. The dashed circles around the proteins indicate that these enzymes are the rate-limiting step in carotenoid biosynthesis. The proteins in green color indicate that the genes encoding these proteins are overexpressing. The dashed arrows indicate multiple steps. The red forks indicate derepression. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 4

### 3.2.1. Engineering the MVA pathway to maximize IPP precursor supply {#sec3.2.1}

In the MVA pathway, the intermediate hydroxymethylglutaryl-CoA (HMG-CoA) can be toxic to cells ([@bib104]) and thus the low expression level of HMG-CoA reductase is one of the rate-limiting steps in the MVA pathway. This can be solved by HMG-CoA overexpression ([@bib135]; [@bib143]) or replacement with a more active one from *Staphylococcus aureus* ([@bib127]). The expression of mevalonate kinase (MK) can be strongly feedback inhibited by GPP and FPP ([@bib35]; [@bib52]). Directed evolution ([@bib8]) and overexpression ([@bib21]) of MK has been applied to increase yields of IPP downstream products. In addition, several feedback-resistant MKs have been identified and characterized ([@bib65]; [@bib106]), which can be expressed in other microorganisms for carotenoid overproduction. Similarly, 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGR1) can be feedback inhibited by FPP, which limits the carotenoid yield. This problem can be alleviated by overexpressing an N-terminal truncated HMGR1 (tHMGR1) ([@bib34]; [@bib105]). Overexpression of key enzymes is not always an ideal solution for supplementing IPP, however, as a balanced expression system can improve carotenoid production and eliminate bottlenecks within the pathway. Overexpression of the first three genes involved in the upper MVA pathway can lead to accumulation of HMG-CoA and result in poor cell growth and low MVA production, but modulating expression of these genes by selecting promoters and controlling copy number increased MVA production by 700% ([@bib104]). Moreover, optimized expression of the upper MVA pathway by tunable intergenic regions (TIGRs) ([@bib103]), which uses oligonucleotides to control the stability of mRNA fragments, or scaffold assembly ([@bib37]), which assembles enzymes in a more appropriate ratio, can also increase the IPP precursor supply. Tunable expression of the lower MVA pathway led to an increase of zeaxanthin production ([@bib117]). For tunable expression of the whole MVA, galactose regulated promoters were attached to the genes of the MVA pathway, which can decrease generation of toxic intermediates and increase IPP supply ([@bib142]). In addition, deletion of *ROX1*, a transcriptional regulator that inhibits genes involved in the MVA pathway ([@bib98]), can also enhance the IPP supply ([@bib15]). All the above modifications focus on cytoplasm engineering, however, mitochondria are another compartment that produces large amounts of acetyl-CoA, the precursor for the MVA pathway. Localized expression of the entire MVA pathway in mitochondria increases the supply of acetyl-CoA and significantly improved the yield of the IPP downstream product isoprene in *S. cerevisiae* ([@bib88]). These strategies to improve flux through the MVA pathway can be applied for enhancement of carotenoid production.

### 3.2.2. Engineering the MEP pathway to maximize IPP precursor supply {#sec3.2.2}

In the MEP pathway, 1-deoxyxylulose-5-phosphate synthase (Dxs) and 1-deoxyxylulose-5-phosphate reductoisomerase (Dxr), which catalyze the first two steps, are generally considered as the key rate-limiting enzymes. Overexpression of *dxs* has been widely applied to increase carotenoid production in bacteria ([@bib48]; [@bib130]; [@bib174]). The product catalyzed by Dxs, DXP, is also the substrate for thiamine and pyridoxal synthesis in *E. coli* ([@bib60]), which can reduce the flux into the MEP pathway. Besides down-regulation of these pathways, DXP can also be synthesized from ribulose 5-phosphate by introducing a shunt pathway ([@bib69]), which can be applied to increase the total DXP concentration. During overexpression of genes in the MEP pathway, methylerythritol cyclodiphosphate (MEcPP) was found to secret from the cells, which can be reduced by overexpressing 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase (IspG) that used MEcPP as a substrate ([@bib173]). Moreover, overexpression of the iron-sulfur cluster operon, which supplies the cofactor for IspG and 4-hydroxy-3-methylbut-2-enyl diphosphate reductase (IspH) ([@bib177]), can increase the IPP precursor supply.

An additional challenge to increase flux through this pathway is to eliminate feedback inhibition. IPP and DMAPP inhibit Dxs ([@bib9]) and FPP inhibits IspF ([@bib18]), which can limit downstream bacterial carotenoid production. Introducing the heterologous MVA pathway into bacteria, which can evade endogenous feedback regulation, has been developed to offset feedback inhibition in the MEP pathway and improve the overall concentration of IPP ([@bib48]; [@bib157]; [@bib178]). In addition, introducing both pathways simultaneously provides a synergistic effect. The MVA pathway provides a net gain of NADPH, which provides reducing power for ATP formation, a highly required cofactor in the MEP pathway. This synergistic effect contributed to improving overall lycopene production in *E. coli* ([@bib156]). To functionally introduce the MEP pathway into eukaryotes, the last two steps catalyzed by IspG and IspH were bottlenecks that needed to be alleviated ([@bib17]; [@bib101]). A number of orthologous genes encoding IspG and IspH, as well as the redox partners flavodoxin (Fld) and flavodoxin/ferredoxin NADP^+^-reductase (FNR) from different species were screened and characterized in *S. cerevisiae* ([@bib68]). *ispG* from *Bacillus thuringiensis IBL 200*, *ispH* from *E. coli* and *fld* from *Bacillus subtilis subsp. subtilis str. 168* resulted in the highest amounts of flux through the MEP pathway for carotenoid biosynthesis in *S. cerevisiae*. More attempts are needed to explore the regulation of the MEP pathway and the relationship between the MEP and MVA pathways in eukaryotes.

### 3.2.3. Introducing the novel isopentenol utilization pathway to provide a new pathway for IPP precursor supply {#sec3.2.3}

As shown above, a lot of attempts have been applied to improve the efficiency of the MEP and MVA pathways, although these attempts still rely on the initial substrate for regulation. A novel IUP was constructed and produced nearly 100-fold more IPP than the MEP pathway within 5 ​mins ([@bib19]). More than 95% of carbon from the target product taxadiene came from IUP compared to less than 5% from the MEP pathway, suggesting that IUP can be an efficient pathway for IPP supply in carotenoid biosynthesis. Moreover, IUP is thought to be non-regulated by any pathway intermediates ([@bib140]), which can significantly increase flux into IPP synthesis. One major limitation to using isoprenoid alcohol as a feedstock is the fact that it is derived from chemical synthesis, which means that any downstream product must be marketed as non-natural. In order to circumvent this problem, an isoprenoid alcohol (IPA) pathway was constructed with novel enzymes that use glycerol as the carbon source and IPA as a natural intermediate ([@bib27]). More attempts are needed, however, to optimize the natural supplement of isoprenoid alcohol due to the low efficiency of the IPA pathway ([@bib27]).

### 3.2.4. Engineering the isomerization of IPP {#sec3.2.4}

After IPP generation, isopentenyl diphosphate isomerase (Idi), which catalyzes the isomerization of IPP to DMAPP, is a key rate-limiting enzyme for carotenoid biosynthesis ([@bib12]). The function of Idi is limited by its low expression level, enzyme activity, short half-life, and weak substrate affinity ([@bib110]). Overexpression of *idi* from several species has been applied to increase carotenoid production ([@bib32]; [@bib169]). Type 2 Idi (mainly exists in plants, some gram-positive eubacteria and archaea) tends to perform better than the type 1 (has a conserved cysteine in the NxxCxHP consensus sequence and a conserved glutamate in the ExE consensus sequence that encode for the active site and mainly exists in plants, mammals, some Gram-positive eubacteria and most Gram-negative eubacteria) for isoprenoid production in *E. coli* ([@bib109]). In addition, directed evolution of *idi* from *S. cerevisiae* increased its activity and affinity, leading to a 1.8-fold increase of lycopene production in *E. coli* ([@bib20]).

3.3. Engineering the central carbon module {#sec3.3}
------------------------------------------

Acetyl-CoA, G3P, and pyruvate, the precursors of the MVA and MEP pathways, are also the substrates for many other pathways. The 'push-pull' strategies that limit their bypass are the most common approaches for improving the supply of these precursors for carotenoid synthesis ([Fig. 4](#fig4){ref-type="fig"}). In addition, increasing the flux from carbon sources and balancing the precursors are also important for carotenoid overproduction.

In the MVA pathway, three acetyl-CoAs are required for each isoprene unit. Acetyl-CoA is also the precursor to lactate, acetate, and ethanol so elimination of these byproducts can lead to an improvement of carotenoid production ([@bib67]; [@bib80]). In addition, reducing the acetyl-CoA consumption in the TCA cycle by a knock-out of the gene encoding for the subunit of 2-oxoglutarate dehydrogenase (SucA) increased more flux into the MVA pathway ([@bib138]). In *S. cerevisiae*, the only cytosolic route to produce acetyl-CoA is from activation of acetate but the glycolytic flux trends toward ethanol formation during glucose cultivation ([@bib107]). Overexpression of cytosolic acetaldehyde dehydrogenase (Ald6p) and acetyl-CoA synthetase (Acs) from *Salmonella enterica* can pull acetyl-CoA from acetate ([@bib90]; [@bib119]) and overexpression of alcohol dehydrogenase (Adh2) can prevent ethanol oxidation by acetaldehyde ([@bib24]; [@bib90]). These strategies have been applied to redirect the carbon flux from byproducts to acetyl-CoA. In addition, to increase acetyl-CoA concentrations, redirecting the pentose phosphate (PP) pathway to supply acetyl-CoA ([@bib94]) and directly converting pyruvate to acetyl-CoA ([@bib80]) has been used to enhance carotenoid production.

In the MEP pathway, G3P and pyruvate are both precursors and utilized in equal amounts. Limitations on either of these precursors are sufficient to reduce carotenoid biosynthesis. G3P is considered a major bottleneck, as G3P is mainly converted to pyruvate and the flux is biased to pyruvate. Redirecting the flux from pyruvate to G3P by downregulation of glyceraldehyde 3-phosphate dehydrogenase (GapA) ([@bib61]) or overexpressing phosphoenolpyruvate (PEP) synthase (Pps) ([@bib40]) increased lycopene production in *E. coli* by 45% and 250%, respectively. In addition, regulated expression of *pps* that is controlled by acetyl-phosphate-inducible artificial Ntr regulons increased pyruvate utilization, leading to an increase of lycopene production ([@bib39]). The Entner-Doudoroff (ED) pathway, which produces equal amounts of G3P and pyruvate, can also be utilized and optimized for carotenoid overproduction ([@bib77]; [@bib81], [@bib82]).

Acetyl-CoA, G3P, and pyruvate are mainly derived from an initial carbon source, which is glucose in most cases ([@bib14]). Enhancing glucose uptake by replacing the PEP-dependent phosphotransferase system with the ATP-dependent galactose permease and glucose kinase system can increase flux into the MEP pathway ([@bib164]) and thus can be applied for carotenoid overproduction. Besides glucose, utilizing xylose as a carbon source by pathway engineering can increase flux from ethanol to acetyl-CoA and provide an additional substrate for carotenoid production ([@bib51]; [@bib72]; [@bib121]).

3.4. Engineering the cofactor module {#sec3.4}
------------------------------------

NADPH and ATP, the cofactors of the MVA and MEP pathways, are critical to carotenoid biosynthesis. Sixteen molecules of NADPH, eight molecules of ATP and eight molecules of CTP are required for one molecule of β-carotene derived through the MEP pathway ([@bib4]). Two NADPH are required for HMGR in the MVA pathway ([Fig. 4](#fig4){ref-type="fig"}). NADPH mainly comes from the PP pathway and TCA cycle ([@bib115]). In order to regenerate and increase the amount of NADPH needed for carotenoid overproduction, multiple strategies have been used to engineer the PP pathway, including overexpressing glucose-6-phosphate dehydrogenase (Zwf1) ([@bib168]) or overexpressing transketolase I (TktA) and TransaldolaseB (talB) ([@bib167]). Engineering the TCA cycle by overexpression of malate dehydrogenase (Mdh) ([@bib26]) or citrate synthase (GltA), α-ketoglutarate dehydrogenase (SucAB), and succinate dehydrogenase (SdhABCD) ([@bib167]) can also improve NAD(P)H supply and carotenoid production. In addition, activating NADPH production by optimized expression of a transcription factor Stb5 that can regulate genes in the pentose phosphate pathway increased lycopene production by 14% ([@bib53]). Likewise, overexpression of a mitochondrial NADH kinase (Pos5) that converts NADH to NADPH increased both lycopene and β-carotene production ([@bib168]). To balance NADPH, limiting off-target consumption, such as knocking out the gene encoding glutamate dehydrogenase (GdhA) ([@bib4]; [@bib26]) or the non-essential NADPH-dependent aldehyde reductase YjgB ([@bib170]) to increase NAPDH accumulation can also be applied to increase carotenoid production.

ATP is synthesized through ATP synthase and the electron transfer chain in *E. coli*. Increasing the ATP supplement by modulating expression of NADH-quinone oxidoreductase, cytochrome bd-I oxidase, cytochrome bo oxidase and ATP synthase enhanced β-carotene production by 120% ([@bib167]). Furthermore, several novel synthetic cofactor systems, such as a rewired ED pathway that can increase NADPH and/or ATP supplements ([@bib71]; [@bib97]) are potential powerful tools for carotenoid overproduction.

3.5. Multi-module engineering for flux balance {#sec3.5}
----------------------------------------------

Focusing on engineering one module can increase accumulation of the precursors required for subsequent modules, leading to potential toxicity (e.g. IPP and DMAPP ([@bib43])) and suboptimal production, resulting in unwanted bottlenecks. Multi-module engineering can solve the bottlenecks between adjacent modules and drive the flux into carotenoid biosynthesis. Combining the engineering of the MEP pathway, ATP and NADPH supply, and β-carotene biosynthesis pathway in *E. coli* led to 2100 ​mg/L β-carotene in a bioreactor ([@bib167]). Step-by-step engineering of the MVA pathway, β-carotene biosynthesis pathway, NAPDH supply, and carotenoid storage in *S. cerevisiae* led to an accumulation of 2370 ​mg/L β-carotene in a bioreactor ([@bib90]). In addition, different modules can be spatially segregated in two different microbes, which allows for taking advantage of different cellular machinery that is optimized for a specific module and avoiding overburdening one host cell. For example, co-culture of an engineered *E. coli*, which harbors the taxadiene biosynthesis module and has a faster growth rate than yeast, with an engineered *S. cerevisiae* that harbors the taxane biosynthesis module and has an efficient protein expression system, leads to complex taxane overproduction ([@bib171]). These experiments can provide novel insights into complex carotenoid biosynthesis.

Though these combined modules can easily obtain high yields of carotenoids, the flux balance between different modules is still difficult to probe. Optimized expression level of modules, known as MMME, is a powerful strategy to balance different modules. The expression level of the MEP pathway and taxane biosynthesis pathway were modulated by promoter engineering and optimizing gene copy number, leading to taxane overproduction ([@bib2]). To better optimize module expression, experimental design-aided systematic pathway optimization (EDASPO) was developed, which can decrease the time cost and the overall workload ([@bib164]). Using this method, experimental data were analyzed using a linear regression model and allowed researchers to screen promoters that would optimize module efficiency. Though promoter screening can enhance the overall module expression level, individual gene expression levels within the module need to be adjusted as well to reduce accumulation of intermediates. Therefore, a multidimensional heuristic process was developed to coordinate intra-module activities by RBS screening and enzyme variants ([@bib163]). This method regulated transcription as well as translation and enzyme activity of fifteen essential genes that were partitioned into four modules, leading to 320 ​mg/L astaxanthin production in *E. coli*. To improve modular pathway engineering, statistical-based modeling to predict optimal gene expression levels is another important tool ([@bib150], [@bib151]). In addition, regulation of the key enzymes can also balance the flux between different modules. Directed co-evolution of *idi*, *dxs* and *dxr*, which balanced the expression levels between the isoprene supplement and carotenoid biosynthesis modules ([Fig. 1](#fig1){ref-type="fig"}), increased lycopene production by 80% in *E. coli* ([@bib87]). Linking Idi and CrtE, which are the key enzymes in the isoprene supplement and carotenoid biosynthesis modules ([Fig. 1](#fig1){ref-type="fig"}), by short peptide tag assembly leads to a 58% increase of lycopene production in *S. cerevisiae* ([@bib64]). By linking these enzymes from different modules together, it is hypothesized to improve conversion and reduce the accumulation of intermediates that cause pathway bottlenecks.

Overproduction of carotenoids, which are secondary metabolites, can increase the metabolic burden of the host and thus decrease cell growth, which can be alleviated by dynamic control of modules to separate cell processes into a growth phase that achieve a high cell density and a production phase that focuses on carotenoid overproduction. An inducer/repressor-free sequential control strategy that repressed carotenoid biosynthesis during the growth phase through the use of a glucose-repression promoter was used to obtain a high cell density. After consumption of the glucose during the growth phase, carotenoid synthesis was activated and carotenoid overproduction could be achieved without sacrificing cell density, leading to 1156 ​mg/L β-carotene in a bioreactor ([@bib149]). Moreover, a quorum-sensing system were developed in *B. subtilis* that can control transcription of target genes based on cell density ([@bib30]). This system was utilized to maximize production of menaquinone-7 by controlling flux through the central carbon module, IPP supplement module and essential byproduct pathway during different phases of fermentation. This system could be used to regulate similar modules in other organisms for carotenoid overproduction. In addition, rewiring gene expression with feedback genetic circuits and microbial interactions to maintain metabolic homeostasis and balance the cell growth fitness and productivity ([@bib89]; [@bib152]) can aid in improving carotenoid production by limiting carotenoid synthesis until after the growth phase is complete.

In addition, omics analysis is a useful tool to better understand the entire cell performance and can further improve carotenoid production. Comparative proteomic analysis of a zeaxanthin overproduction strain ([@bib117]) and transcriptomic analysis of a lycopene strain using fructose as carbon source ([@bib36]) identified regulated pathways and genes that can be further enhanced for carotenoid production. From the comparative proteomic analysis ([@bib117]), a correlation of the precursor pool, cofactor availability, oxidative stress response, membrane storage capacity, and cell morphology with increased zeaxanthin production was observed. From the transcriptomic analysis ([@bib36]), 384 differentially expressed genes involved in pyruvate catabolism, tricarboxylic acid cycle, and oxidative phosphorylation were identified and are thought to provide more precursors, cofactors and energy needed for growth and lycopene production. For pathway regulation, transcription factors not only regulate expression of specific genes, but also entire pathways, making them important targets for intramodular engineering. For example, overexpressing sigma factors sigA ([@bib123]), an important cofactor in the MEP pathway, and rpoD ([@bib59]), a cofactor involved in altering cellular oxidative status, increases carotenoid production in *C. glutamicum* and *E. coli*, respectively.

In addition to modular engineering, computational or random systemic engineering have been applied to identify gene targets that would lead to a global phenotype optimum. A genome-wide stoichiometric flux balance analysis, which calculates metabolic fluxes by flux balance analysis and identifies potential knockout genes by minimization of metabolic adjustment (MOMA), was developed for discovering putative genes impacting network properties and cellular phenotype ([@bib4]; [@bib10]). Using this method, knockouts of three simulated genes increased lycopene production by 40% ([@bib4]). To identify the potential amplification genes, genomic library screening by systematic and combinatorial approaches ([@bib59]) and flux scanning based on enforced objective flux (FSEOF) ([@bib26]) were developed. Using FSEOF, potential genes are selected based on metabolic flux scanning, which selects fluxes toward product formation. Eight genes were identified to amplify for lycopene overproduction by FSEOF, leading to an increase of 523% ([@bib26]).

Due to the many unknown kinetic and regulatory factors that are unaccounted for in stoichiometric models and cannot be considered by computational simulation, random targeting and screening is also applied for carotenoid overproduction. Targets were identified by colorimetric screening of a shot-gun library ([@bib63]), a global transposon library search ([@bib5]), and modeling and transposon mutagenesis ([@bib6]) for improving lycopene production. In addition, mutagenesis by atmospheric and room temperature plasma (ARTP) has been employed to generate a mutagenesis library in *S. cerevisiae*, one of which had a 83% increase in astaxanthin yield ([@bib57]). To generate a mutagenesis library of programming multiple target genes, multiplex automated genome engineering (MAGE) based on the RecT recombinase was developed in *E. coli*, one of which had a nearly 450% increase in lycopene yield ([@bib137]).

4. Conclusion and outlook {#sec4}
=========================

Metabolic engineering techniques have greatly improved carotenoid overproduction in microorganisms. Novel enzyme and target gene screening, protein engineering, and regulation tools have been successfully applied in the central carbon metabolism module, cofactor metabolism module, isoprene supplement metabolism module and carotenoid biosynthesis module for improved carotenoid production. Few engineered microbial carotenoid strains, however, are widely applied in industry and more efforts are needed for microbial carotenoid overproduction. First, the genetic stability of microbial strains limits their application in industry. Only a few bioprocesses focus on chromosomal genes and most still use plasmids for gene regulation, which are less stable, requires antibiotics and bear a higher metabolic burden ([@bib41]). Several strategies have been employed to solve these problems, such as novel marker-free genetic integration tools based on the CRISPR-Cas system ([@bib70]; [@bib83]), stable gene expression systems based on an incoherent feedforward loop (iFFL) ([@bib116]) and antibiotic-free plasmids based on Stable and TunAble PLasmid (STAPL) system that encode for translation initiation factors required by a corresponding auxotroph ([@bib62]). Second, most enzymes of carotenoid biosynthesis are from plants and have a low catalytic efficiency in microorganisms. Novel enzyme screening ([@bib46]) and protein evolution ([@bib147]), assisted with machine learning, can be applied to obtain efficient enzymes. Moreover, unnatural base pairs ([@bib166]) and unnatural amino acids ([@bib111]) can make protein evolution more diverse. Third, though several omics analyses have been done in carotenoid overproduction strains, the relationship between pathway regulation and metabolite consumption must be better understood. Coupling multi-omics analysis, including transcriptomics, proteomics and metabolomics can lead to a deeper understanding of carotenoid biosynthesis, which is beneficial for bottleneck analysis and carotenoid overproduction. Fourth, carotenoids are secondary metabolites, that when overproduced, can be a burden to the overall cell metabolism. The IUP that used isoprenol as a secondary substrate to supply IPP, which does not have to compete with the rest of the cell for carbon flux ([@bib19]), can relieve this metabolic burden. Due to the toxicity of isoprenol, improvement of the IUP is needed to increase carotenoid yield. Nevertheless, further efforts, including but not limited to these approaches, will be required to better understand carotenoid biosynthesis and improve microbial engineering for carotenoid overproduction.
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